Does ProKidney Corp (NASDAQ:PROK) presents a BIG investment opportunity?
In yesterday’s Wall Street session, ProKidney Corp (NASDAQ:PROK) shares traded at $1.86, up 5.68% from the previous session. As of this writing, 6 analysts cover ProKidney Corp (NASDAQ:PROK). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $15.00 and a low of […]
